Paeds Vivas · allergy-and-immunology
Antibody deficiencies — branching viva
Branching viva on antibody deficiencies in children: recognising the recurrent-infection pattern that earns an immunoglobulin work-up, interpreting the work-up functionally with a vaccine response, classifying into a primary inborn error or a secondary cause, deciding who needs immunoglobulin replacement, and protecting the lung.
On this page & tools
Target exams
Opening question
Take me through your framework when a child presents with recurrent infection that you suspect might be due to an antibody deficiency. [1] [2]
Branch 1 — the likely diagnosis
The boy has absent tonsils and lymph nodes, pan-hypogammaglobulinaemia, and absent B cells, presenting after maternal antibody wanes. What is the most likely diagnosis, which gene is implicated, and why does the timing fit? [3]
Branch 2 — confirming the defect
How will you confirm this diagnosis, and why is a functional vaccine response important even though the immunoglobulins are already clearly low? What does the absence of B cells tell you that the low IgG alone does not? [2] [6]
Branch 3 — long-term management
Outline the principles of long-term management: immunoglobulin replacement, infection prophylaxis, lung surveillance, and genetic counselling for the mother's carrier relatives. What is the prognosis with consistent therapy? [3] [4]
Branch 4 — the contrasting case (the trap)
Now picture a thriving two-year-old with a single low IgG but a preserved vaccine response and B cells present. Why would you NOT start immunoglobulin here, and what is the expected natural history? What would make you escalate? [6] [4]
Closing — the general rule
In one sentence, what is the single rule that decides whether a child with low immunoglobulins receives immunoglobulin replacement, and why does over-treatment matter as much as under-treatment? [2] [6]
References
- [1]Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol, 2007.PMID 17577648
- [2]Bousfiha A, Moundir A, Tangye SG, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol, 2022.PMID 36198931
- [3]Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore), 2006.PMID 16862044
- [4]Ameratunga R, Woon ST, Brewerton M, et al. Diagnostic criteria for common variable immunodeficiency disorders. J Allergy Clin Immunol Pract, 2016.PMID 27587325
- [6]Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract, 2019.PMID 30776527